Devyser´s annual report 2021 has today been published on the company´s website.
The report is available on: https://investors.devyser.com/en/reports-presentations
The financial year…
Another record quarter
"Devyser’s sales were also strong in the fourth quarter 2021, as well as in the other quarters of the year. We have continued to feel the impact of the pandemic,…
On Thursday February 24, at 09.00 CET, Devyser Diagnostics AB will host a conference call and an online presentation of its Q4 2021 interim report (which will have been published earlier…
Stockholm, February 7, 2022 - Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announced that the company has utilized an option to acquire all of the…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, JAPAN, CANADA, AUSTRALIA OR ANY OTHER JURISDICTION IN…
Stockholm, 29 December, 2021
Carnegie Investment Bank AB (publ) (“Carnegie”) has undertaken stabilisation measures in Devyser Diagnostics AB (publ)’s (“Devyser” or the “Company”) shares…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, JAPAN, CANADA, AUSTRALIA OR ANY OTHER JURISDICTION IN…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, JAPAN, CANADA, AUSTRALIA OR ANY OTHER JURISDICTION IN…
Continued focus on increased direct sales
"The second half of the year started off very well for Devyser. Sales remained strong during the quarter, and operations continued to develop in…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, JAPAN, CANADA, AUSTRALIA OR ANY OTHER JURISDICTION IN…
